European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. - Wikidata - awgldk - TriplyDB

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

http://www.wikidata.org/entity/Q34787789

about

Lyme Neuroborreliosis: Manifestations of a Rapidly Emerging Zoonosis Cutaneous primary B-cell lymphomas: from diagnosis to treatment Early lymphoid lesions: conceptual, diagnostic and clinical challenges Cutaneous lymphomas Frequency of primary cutaneous lymphoma variants in Austria: retrospective data from a dermatology referral centre between 2006 and 2013.Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.A Case of Cutaneous Diffuse Large B-cell Lymphoma.Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.Overview of alemtuzumab therapy for the treatment of T-cell lymphomas.Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.The microbiome and cancer.The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysis MicroRNA profiling of primary cutaneous large B-cell lymphomas TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial Primary cutaneous large B-cell lymphoma, leg type Primary cutaneous large B-cell lymphoma, leg type: Report of two cases and review of literature.Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.Age, race, sex, stage, and incidence of cutaneous lymphoma Primary cutaneous lymphomas: A clinical and histological study of 99 cases in Isfahan, Iran.Excellent Outcome of Immunomodulation or Bruton's Tyrosine Kinase Inhibition in Highly Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports.Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies.A Literature Revision in Primary Cutaneous B-cell Lymphoma Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature Current therapy of choice for cutaneous lymphomas: Complementary to the Japanese Dermatological Association/Japanese Skin Cancer Society guidelines.Ureteral spread of a primary cutaneous diffuse large B-cell lymphoma, leg type.Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions.Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.Primary Cutaneous Lymphomas in Children and Adolescents.Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management.Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: A case report and review of literature.Microbiota: a key orchestrator of cancer therapy.Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?Intralesional anti-CD20 antibody for low-grade primary cutaneous B-cell lymphoma: Adverse reactions correlate with favorable clinical outcome.

P2860

Q22241251-CFC7A9C6-0213-475F-8E12-A4F5A59E116A Q26777479-71D8C61A-2BD3-4F29-BA93-9DA50D4DD022 Q26996519-188370AD-78F4-4A87-904B-057A4A71F1E2 Q27693872-B5751F43-2E97-423F-82A7-DDC77D99BAAA Q30884958-C2980C61-4CE8-4A12-BEB5-8FD3B20F8423 Q33739823-0CDB355F-AC42-4A5A-82B4-83C199211854 Q33914879-23445363-C560-41BF-AAE5-21B8A8AB2A9C Q33930161-7B3D645F-B9D4-46DA-B9E5-456085BABE1E Q34222228-31794345-E330-40E1-B26B-A4592006B713 Q34282565-63DC66DC-A14B-4F76-8D87-F5043B48D0E6 Q34455355-5AC1D6BD-4BE1-453B-A952-0FC807154AD3 Q35019302-B81ADF9D-5896-4938-94EA-471A58C5766B Q35040896-D069E2B8-4C9B-40EE-A02F-B82793A13F5B Q35072776-ADFC65A4-049D-433B-A60C-C807A96D8F6C Q35105819-A53AAA19-AF41-49D3-AA38-3D11C21CD3D8 Q35488493-5500B070-F8AC-4F21-BF0D-823C8B469713 Q36064391-4685C020-93D2-4CC7-8AE1-59C7436A8B9A Q36116337-94F1AF15-E699-410C-A316-4884577F5CC7 Q36330634-11C24E45-055E-40D2-BF95-30B9FE3A68FC Q36417250-DF0B2A9D-E655-4835-A76C-167239FAF23E Q36438238-77CA3165-2F0C-4623-93D2-0C675AFB470B Q36967098-C0590EE9-C95C-4AC5-81B3-1D631877B72A Q37323796-FBBB2868-E629-47E2-AF6D-36A6529AEB6D Q37700771-0F784B05-E3AA-4CB5-96FF-64320B5C2E4D Q37717714-8EF1C4EB-3B3B-47B6-8490-BF337EA4319A Q37944372-FEE4A9ED-D12B-49A0-8101-2968CF79BEA6 Q38023593-A93455C1-21C6-435F-9F58-10144CF678ED Q38035410-08F48418-515C-4529-BE9D-534E9027837C Q38078943-E98FAD01-8181-457B-A2C3-6CCBCCB98EF6 Q38115866-BD5BE5E7-A61A-4652-9667-979A58C9394B Q38179493-11774E13-34AA-465B-B95A-430EAA822380 Q38800801-D7925574-0973-4D19-B14E-4A9F89908579 Q38805440-8E7CE3FA-CE40-433F-8AA1-460865B2F843 Q38813983-091A9B73-1295-4C99-A1BE-81E1C93A4406 Q38845166-0961AA4C-7924-457B-991F-6FCEBB08E250 Q38960140-41DEBA70-E8AC-43F8-A2C4-83087F301AF2 Q39146536-2630AC4F-1A20-420E-BC47-429AE475CF8C Q39183428-1F2E89BC-0775-4EB8-95E5-DB3183F6FE64 Q39512586-845AAC4A-40DC-467C-84B8-4FB8E80C612A Q40069811-35DE4796-A4A4-4B0E-9B94-8EF8DA8E0B64

P2860

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

http://www.wikidata.org/entity/Q34787789

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@ast

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@en

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@nl

type

label

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@ast

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@en

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@nl

prefLabel

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@ast

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@en

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@nl

P1433

Q34787789-DE0C117D-D3F5-4DB6-B828-01783FA54777

P1476

Q34787789-F160DBC0-72FB-422E-9567-A88904F64A7B

P2093

Q34787789-051C1CBB-AD36-4094-B269-C7824DF7CAC5

Q34787789-1597715D-C19D-4F0A-9D2D-6588EEB61D13

Q34787789-3776646F-6CBA-4324-9016-3B264F05DA68

Q34787789-52C1C9E0-5F15-4463-AF6C-77D593711002

Q34787789-54AED0CE-3805-4C26-906D-FB828AC4BD24

Q34787789-6428F8FF-B651-491A-BA8E-A3865FC2901C

Q34787789-69B85197-0D7F-42A2-9D86-419A1E4CD4CA

Q34787789-806B7093-2374-4F35-909E-4541D527CF02

Q34787789-9A2F64F3-DD6A-46AB-9ACD-CA144B314C55

Q34787789-B0CBCE84-596B-450B-897F-E97E726E8E92

P304

Q34787789-256C00F1-4D04-4DF4-BC98-B753FFB62B7D

P31

Q34787789-CECAA4DF-AA91-4022-A50E-D16C9BF8621A

P356

Q34787789-B152246C-6707-40D5-A657-4F782AF4E009

P407

Q34787789-4F2A214E-0C71-4969-A35B-DD2494792A0C

P433

Q34787789-A4BAFFE3-6B36-4359-8BAB-DC73C315266E

P478

Q34787789-721B0EAF-598C-4460-8967-6D7D94A2F581

P50

Q34787789-D850834C-0018-459E-ACD1-1A4AD3328674

P577

Q34787789-BE3EA191-55A3-4990-940E-D003E97B2E5A

P5875

Q34787789-84F54A35-24B3-4E3E-82EC-0A7E86747814

P698

Q34787789-60463ED2-E278-466B-9821-F94C176B4810

P356

BLOOD-2008-04-152850

P1433

P1476

European Organization for Rese ...... of cutaneous B-cell lymphomas.

@en

P2093

European Organization for Research and Treatment of Cancer

http://www.w3.org/2001/XMLSchema#string

Evert M Noordijk

http://www.w3.org/2001/XMLSchema#string

International Society for Cutaneous Lymphoma

http://www.w3.org/2001/XMLSchema#string

Lorenzo Cerroni

http://www.w3.org/2001/XMLSchema#string

Maarten H Vermeer

http://www.w3.org/2001/XMLSchema#string

Madeleine Duvic

http://www.w3.org/2001/XMLSchema#string

Martine Bagot

http://www.w3.org/2001/XMLSchema#string

Nancy J Senff

http://www.w3.org/2001/XMLSchema#string

Nicola Pimpinelli

http://www.w3.org/2001/XMLSchema#string

Rein Willemze

http://www.w3.org/2001/XMLSchema#string

P304

1600-1609

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-04-152850

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5288425

http://www.w3.org/2001/XMLSchema#string

P698

18567836

http://www.w3.org/2001/XMLSchema#string